Literature DB >> 21379408

Compassionate use of medicinal products in Europe: current status and perspectives.

Mussa Rahbari, Nuh N Rahbari.   

Abstract

Mesh：

Year:  2011        PMID： 21379408      PMCID： PMC3044254          DOI： 10.2471/BLT.10.085712

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  8 in total

1.  Regulation of cell-based therapies in Europe: current challenges and emerging issues.

Authors:  Alessandro Blasimme; Emmanuelle Rial-Sebbag
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

Review 2.  An overview of Compassionate Use Programs in the European Union member states.

Authors:  Gayathri Balasubramanian; Suman Morampudi; Pankdeep Chhabra; Arun Gowda; Behsad Zomorodi
Journal:  Intractable Rare Dis Res       Date:  2016-11

3.  Temporary authorization for use: does the French patient access programme for unlicensed medicines impact market access after formal licensing?

Authors:  Albane Degrassat-Théas; Pascal Paubel; Olivier Parent de Curzon; Claude Le Pen; Martine Sinègre
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

4.  A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.

Authors:  Mohammad S Sadaghiani; Sara Sheikhbahaei; Rudolf A Werner; Kenneth J Pienta; Martin G Pomper; Lilja B Solnes; Michael A Gorin; Nae-Yuh Wang; Steven P Rowe
Journal:  Eur Urol       Date:  2021-04-08       Impact factor: 20.096

Review 5.  Stem cell therapy: from evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation.

Authors:  Paola Frati; Giacomo Frati; Matteo Gulino; Gianluca Montanari Vergallo; Alessandro Di Luca; Vittorio Fineschi
Journal:  Stem Cell Res Ther       Date:  2013-10-11       Impact factor: 6.832

6.  Global Access Programs: A Collaborative Approach for Effective Implementation and Management.

Authors:  Debra Ainge; Suzanne Aitken; Mark Corbett; David De-Keyzer
Journal:  Pharmaceut Med       Date:  2015

7.  177 Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysis.

Authors:  Mohammad S Sadaghiani; Sara Sheikhbahaei; Rudolf A Werner; Kenneth J Pienta; Martin G Pomper; Michael A Gorin; Lilja B Solnes; Steven P Rowe
Journal:  Prostate       Date:  2022-03-14       Impact factor: 4.012

8.  Characteristics of the Compassionate Use Program in Japan: An Analysis of Expanded Access Clinical Trials from 2016 to 2021.

Authors:  Hideki Maeda; Marika Uchida; Mikiko Kusano; Katsura Tsukamoto; Moeka Yamanoi
Journal:  Clin Pharmacol Ther       Date:  2022-06-07       Impact factor: 6.903
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.